Chi, Dennis

Selected publications

Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery. Journal of Gynecologic Oncology. 2020 Academic Article GET IT
Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomes. Gynecologic Oncology. 2020 Academic Article GET IT
Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy. Gynecologic Oncology. 2020 Academic Article GET IT
Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer. Obstetrical and Gynecological Survey. 2019 Comment GET IT
Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation status. Gynecologic Oncology. 2019 Academic Article GET IT
Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center. Gynecologic Oncology. 2019 Academic Article GET IT
Times cited: 2
Secondary surgical resection for patients with recurrent uterine leiomyosarcoma. Gynecologic Oncology. 2019 Academic Article GET IT
Exploring the impact of income and race on survival for women with advanced ovarian cancer undergoing primary debulking surgery at a high-volume center. Gynecologic Oncology. 2018 Academic Article GET IT
Times cited: 3
A prospective trial of acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancer. Gynecologic Oncology. 2018 Academic Article GET IT
Times cited: 4
Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival?. Gynecologic Oncology. 2018 Academic Article GET IT
Times cited: 8
It's time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer. Gynecologic Oncology. 2018 Academic Article GET IT
Times cited: 6
Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer. Gynecologic Oncology. 2018 Academic Article GET IT
Times cited: 4
Surgical management of ovarian carcinoma. 2018 Chapter
Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer. International Journal of Hyperthermia. 2017 Academic Article GET IT
Times cited: 12
POINT: Primary debulking surgery vs neoadjuvant chemotherapy for newly diagnosed advanced ovarian cancer. ONCOLOGY. 2017 Academic Article GET IT
A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer. Gynecologic Oncology. 2017 Academic Article GET IT
Times cited: 22
Clinical and genetic determinants of ovarian metastases from colorectal cancer. Cancer. 2017 Academic Article GET IT
Times cited: 12
Distinguishing between intramural pregnancy and choriocarcinoma: A case report. Oncology Letters. 2017 Academic Article GET IT
Times cited: 3
Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?. Gynecologic Oncology. 2017 Academic Article GET IT
Times cited: 20
Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes. Gynecologic Oncology. 2017 Academic Article GET IT
Times cited: 11
Bilateral Otorrhagia after Robotically Assisted Gynecologic Surgery in the Setting of a Reduced Trendelenburg Position and Low-Pressure Pneumoperitoneum: A Case Report and Review of the Literature. Journal of Minimally Invasive Gynecology. 2017 Academic Article GET IT
Times cited: 1
Long-term survival after anterior pelvic exenteration and total vaginectomy for recurrent endometrial carcinoma with metastatic inguinal nodes at the time of surgery. Gynecologic Oncology Reports. 2017 Academic Article GET IT
Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care. Gynecologic Oncology. 2017 Academic Article GET IT
Times cited: 5
A Comparison of Thermal Plasma Energy Versus Argon Beam Coagulator-Induced Intestinal Injury after Vaporization in a Porcine Model. International Journal of Gynecological Cancer. 2017 Academic Article GET IT
Times cited: 2
Benign metastasizing leiomyomas thought to be nodal metastases in a case of ovarian cancer. Taiwanese Journal of Obstetrics and Gynecology. 2017 Academic Article GET IT
Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer. Gynecologic Oncology. 2017 Academic Article GET IT
Times cited: 14
Surgical site infection reduction bundle in patients with gynecologic cancer undergoing colon surgery. Gynecologic Oncology. 2017 Academic Article GET IT
Times cited: 10
A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancer. Gynecologic Oncology. 2016 Academic Article GET IT
Times cited: 12
Electronic patient-reported outcomes from home in patients recovering from major gynecologic cancer surgery: A prospective study measuring symptoms and health-related quality of life. Gynecologic Oncology. 2016 Academic Article GET IT
Times cited: 11
Second-Opinion Interpretations of Gynecologic Oncologic MRI Examinations by Sub-Specialized Radiologists Influence Patient Care. European Radiology. 2016 Academic Article GET IT
Times cited: 21
Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes. Gynecologic Oncology. 2016 Academic Article GET IT
Times cited: 13
A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease. Gynecologic Oncology. 2016 Academic Article GET IT
Times cited: 19
Neoadjuvant chemotherapy in ovarian cancer revisited. Annals of Oncology. 2016 Academic Article GET IT
Times cited: 7
Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center. Gynecologic Oncology. 2016 Academic Article GET IT
Times cited: 2
Herniation formation in women undergoing robotically assisted laparoscopy or laparotomy for endometrial cancer. Gynecologic Oncology. 2016 Academic Article GET IT
Times cited: 4
Is It Time to Centralize Ovarian Cancer Care in the United States?. Annals of Surgical Oncology. 2016 Review GET IT
Times cited: 18
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center. Gynecologic Oncology. 2016 Academic Article GET IT
Times cited: 50
Impact of Robotic Platforms on Surgical Approach and Costs in the Management of Morbidly Obese Patients with Newly Diagnosed Uterine Cancer. Annals of Surgical Oncology. 2016 Academic Article GET IT
Times cited: 13
Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center. Gynecologic Oncology. 2016 Academic Article GET IT
Times cited: 5
Is it time to centralize ovarian cancer care in the United States?. Obstetrical and Gynecological Survey. 2016 Comment
Primary debulking surgery for metastatic cervical adenocarcinoma: A case report. Gynecologic Oncology Reports. 2015 Academic Article GET IT
Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery. European Radiology. 2015 Academic Article GET IT
Times cited: 27
There is nothing new under the sun. Journal of Clinical Oncology. 2015 Information Resource GET IT
Times cited: 2
Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer. Gynecologic Oncology. 2015 Academic Article GET IT
Times cited: 9
Ovarian vein thrombosis after debulking surgery for ovarian cancer: Epidemiology and clinical significance. American Journal of Obstetrics and Gynecology. 2015 Academic Article GET IT
Times cited: 3
Cancer of the cervix. 2015 Chapter
Extended surgery for advanced ovarian cancer. 2015 Chapter GET IT
Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer. Gynecologic Oncology. 2015 Academic Article GET IT
Times cited: 33
Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancer. International Journal of Gynecological Cancer. 2015 Academic Article GET IT
Times cited: 6
Radical Surgery in Ovarian Cancer. Current Oncology Reports. 2015 Review GET IT
Times cited: 17
Role of MR imaging and FDG PET/ CT in selection and follow-up of patients treated with Pelvic exenteration for gynecologic malignancies. Radiographics. 2015 Review GET IT
Times cited: 8
Role of aggressive surgical cytoreduction in advanced ovarian cancer. Journal of Gynecologic Oncology. 2015 Review GET IT
Times cited: 54
Postoperative outcomes among patients undergoing thoracostomy tube placement at time of diaphragm peritonectomy or resection during primary cytoreductive surgery for ovarian cancer. Gynecologic Oncology. 2014 Academic Article GET IT
Times cited: 3
A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced Ovarian Cancer. Obstetrical and Gynecological Survey. 2014 Comment
A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer. Gynecologic Oncology. 2014 Academic Article GET IT
Times cited: 6
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer. Gynecologic Oncology. 2014 Academic Article GET IT
Times cited: 104
Cervical conization and sentinel lymph node mapping in the treatment of stage i cervical cancer : Is less enough?. International Journal of Gynecological Cancer. 2014 Academic Article GET IT
Times cited: 25
Cytoreductive surgery for advanced ovarian cancer. Women's Health. 2014 Review GET IT
Times cited: 13
Fellowship learning curve associated with completing a robotic assisted total laparoscopic hysterectomy. Gynecologic Oncology. 2014 Academic Article GET IT
Times cited: 20
Voiding Dysfunction After Non-genitourinary Radical Pelvic Surgery. Current Bladder Dysfunction Reports. 2014 Report GET IT
Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: Risk factors and associations with postoperative morbidity. Gynecologic Oncology. 2013 Academic Article GET IT
Times cited: 11
Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration. International Journal of Gynecological Cancer. 2013 Academic Article GET IT
Times cited: 18
A case report of vulvar carcinoma in situ treated with sinecatechins with complete response. Gynecologic Oncology Reports. 2013 Academic Article GET IT
Times cited: 2
Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration. European Radiology. 2013 Academic Article GET IT
Times cited: 11
Optimal (≤ 1 cm) but visible residual disease: Is extensive debulking warranted?. Gynecologic Oncology. 2013 Academic Article GET IT
Times cited: 17
Expanding the indications for radical trachelectomy a report on 29 patients with stage ib1 tumors measuring 2 to 4 centimeters. International Journal of Gynecological Cancer. 2013 Academic Article GET IT
Times cited: 41
Feasibility of adjuvant chemotherapy after pelvic exenteration for gynecologic malignancies. International Journal of Gynecological Cancer. 2013 Academic Article GET IT
Times cited: 1
The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration. Gynecologic Oncology. 2013 Academic Article GET IT
Times cited: 21
Surgical principles in gynecologic oncology. 2013 Chapter
Times cited: 5
The "definitive" trial of surgical cytoreduction in advanced-stage ovarian cancer. International Journal of Gynecological Cancer. 2013 Article GET IT
Times cited: 4
Management of intravascular leiomyomatosis: Laparoscopic surgery for ordinary uterine fibroids led to an extraordinary finding. American Journal of Obstetrics and Gynecology. 2013 Academic Article GET IT
Radical surgery with individualized postoperative radiation for stage ib cervical cancer; Oncologic outcomes and severe complications. International Journal of Gynecological Cancer. 2013 Academic Article GET IT
Times cited: 6
Validated gene targets associated with curatively treated advanced serous ovarian carcinoma. Gynecologic Oncology. 2013 Academic Article GET IT
Times cited: 27
A prospective study of quality of life in patients undergoing pelvic exenteration: Interim results. Gynecologic Oncology. 2013 Academic Article GET IT
Times cited: 25
Ovarian cancer: Surgical considerations. 2013 Chapter GET IT
Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer. Gynecologic Oncology. 2013 Academic Article GET IT
Times cited: 10
A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery. Gynecologic Oncology. 2012 Academic Article GET IT
Times cited: 23
Location of disease in patients who die from endometrial cancer : A study of 414 patients from a single institution. International Journal of Gynecological Cancer. 2012 Academic Article GET IT
Times cited: 12
Reply to How to improve cytoreductive surgery for advanced ovarian cancer and talk about it in a common language. Gynecologic Oncology. 2012 Information Resource GET IT
Clinical implications of pleural effusions in ovarian cancer. Respirology. 2012 Academic Article GET IT
Times cited: 20
An international series on abdominal radical trachelectomy 101 patients and 28 pregnancies. International Journal of Gynecological Cancer. 2012 Academic Article GET IT
Times cited: 61
Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: Review of surgical technique, complications, and outcome. Gynecologic Oncology. 2012 Academic Article GET IT
Times cited: 11
Covered esophageal self-expandable metal stents in the nonoperative management of postoperative colorectal anastomotic leaks. Gastrointestinal Endoscopy. 2012 Academic Article GET IT
Times cited: 14
Re: "Pelvic exenteration with curative intent for recurrent uterine malignancies". Gynecologic Oncology. 2012 Article GET IT
Response to: "Management of ovarian cancer has changed". Gynecologic Oncology. 2012 Information Resource GET IT
Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer. Gynecologic Oncology. 2012 Academic Article GET IT
Times cited: 12
Early postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgery. American Journal of Roentgenology. 2012 Academic Article GET IT
Times cited: 15
Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer. Gynecologic Oncology. 2012 Academic Article GET IT
Times cited: 33
Reproductive outcomes of patients undergoing radical trachelectomy for early-stage cervical cancer. Gynecologic Oncology. 2012 Academic Article GET IT
Times cited: 63
The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: Beyond removal of blue nodes. Gynecologic Oncology. 2012 Academic Article GET IT
Times cited: 182
Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: An update on out of the box surgery. Gynecologic Oncology. 2012 Academic Article GET IT
Times cited: 19
Introduction of a computer-based surgical platform in the surgical care of patients with newly diagnosed uterine cancer: Outcomes and impact on approach. Gynecologic Oncology. 2012 Academic Article GET IT
Times cited: 20
RE: Defining the limits of radical cytoreductive surgery in ovarian cancer. Gynecologic Oncology. 2012 Information Resource GET IT
Times cited: 2
Reply to W.R. Robinson. Journal of Clinical Oncology. 2012 Article GET IT
Times cited: 1
Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis. Gynecologic Oncology. 2012 Academic Article GET IT
Times cited: 37
Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer. Gynecologic Oncology. 2012 Academic Article GET IT
Times cited: 38
Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer. Gynecologic Oncology. 2012 Academic Article GET IT
Times cited: 12
A case of synchronous pancreatic ductal adenocarcinoma and ovarian mucinous cystic neoplasm: Use of kras mutation molecular phenotyping to demonstrate independent primary origin. Gastrointestinal Cancer Research. 2012 Academic Article GET IT
A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma. Cancer. 2012 Academic Article GET IT
Times cited: 72
A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: An evidence-based proposal for patient selection. Annals of Surgical Oncology. 2012 Academic Article GET IT
Times cited: 59
Current surgical management of ovarian cancer. Hematology/Oncology Clinics of North America. 2012 Review GET IT
Times cited: 28
An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT). Gynecologic Oncology. 2012 Academic Article GET IT
Times cited: 172
Pelvic exenteration with curative intent for recurrent uterine malignancies. Gynecologic Oncology. 2012 Academic Article GET IT
Times cited: 40
Accuracy of frozen section diagnosis of ovarian borderline tumor. Gynecologic Oncology. 2011 Academic Article GET IT
Times cited: 31
The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma. Gynecologic Oncology. 2011 Academic Article GET IT
Times cited: 40
Thoracic metastasis in advanced ovarian cancer: Comparison between computed tomography and video-assisted thoracic surgery. Journal of Gynecologic Oncology. 2011 Academic Article GET IT
Times cited: 11
Treatment of locally recurrent mucosal melanoma with topical imiquimod. Journal of Clinical Oncology. 2011 Academic Article GET IT
Times cited: 21
Is the easier way ever the better way?. Journal of Clinical Oncology. 2011 Academic Article GET IT
Times cited: 60
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort. British Journal of Cancer. 2011 Academic Article GET IT
Times cited: 69
Malignant melanoma of the vulva: An extension of cutaneous melanoma?. Gynecologic Oncology. 2011 Academic Article GET IT
Times cited: 37
Surgical cytoreduction in stage IV endometrioid endometrial carcinoma. Gynecologic Oncology. 2011 Academic Article GET IT
Times cited: 26
Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer. Gynecologic Oncology. 2011 Academic Article GET IT
Times cited: 79
Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes. Gynecologic Oncology. 2011 Academic Article GET IT
Times cited: 101
Complex atypical hyperplasia of the uterus: Characteristics and prediction of underlying carcinoma risk. Obstetrical and Gynecological Survey. 2011 Comment GET IT
Recent surgical management of ovarian cancer. Journal of Obstetrics and Gynaecology Research. 2011 Review GET IT
Times cited: 13
The revised 2009 FIGO staging system for endometrial cancer: Should the 1988 FIGO stages IA and IB be altered?. International Journal of Gynecological Cancer. 2011 Academic Article GET IT
Times cited: 41
Clinical Approach to Diagnosis and Management of Ovarian, Fallopian Tube, and Peritoneal Carcinoma. Surgical Pathology Clinics. 2011 Review GET IT
Times cited: 1
Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: Effect on survival. Radiology. 2011 Academic Article GET IT
Times cited: 27
Risk factors for recurrence of ovarian borderline tumors. Gynecologic Oncology. 2011 Academic Article GET IT
Times cited: 63
Sentinel lymph node biopsy in the management of early-stage cervical carcinoma. Gynecologic Oncology. 2011 Academic Article GET IT
Times cited: 49
Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment. Gynecologic Oncology. 2011 Academic Article GET IT
Times cited: 129
Recovery issues of fertility-preserving surgery in patients with early-stage cervical cancer and a model for survivorship: The physician checklist. International Journal of Gynecological Cancer. 2011 Academic Article GET IT
Times cited: 11
Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers. Gynecologic Oncology. 2011 Academic Article GET IT
Times cited: 11
‘Ultra-radical’surgery in advanced ovarian cancer. 2011 Chapter GET IT
Epithelial ovarian cancer: Focus on targeted therapy. Journal of Oncology. 2010 Academic Article GET IT
Times cited: 3
A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer. Gynecologic Oncology. 2010 Academic Article GET IT
Times cited: 73
Pathologic analysis of ex vivo plasma energy tumor destruction in patients with ovarian or peritoneal cancer. International Journal of Gynecological Cancer. 2010 Academic Article GET IT
Times cited: 6
Patterns of recurrence and role of adjuvant chemotherapy in stage II-IV serous ovarian borderline tumors. Gynecologic Oncology. 2010 Academic Article GET IT
Times cited: 18
Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for uterine or cervical cancers. Gynecologic Oncology. 2010 Academic Article GET IT
Times cited: 7
Complex atypical hyperplasia of the uterus: Characteristics and prediction of underlying carcinoma risk. American Journal of Obstetrics and Gynecology. 2010 Academic Article GET IT
Times cited: 34
Recurrent ovarian cancer: Use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival. Radiology. 2010 Academic Article GET IT
Times cited: 44
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Gynecologic Oncology. 2010 Academic Article GET IT
Times cited: 106
The National Cancer Database report on advanced-stage epithelial ovarian cancer: Impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecologic Oncology. 2010 Academic Article GET IT
Times cited: 140
Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer. International Journal of Gynecological Cancer. 2010 Academic Article GET IT
Times cited: 25
Maximal cytoreductive effort in epithelial ovarian cancer surgery. Journal of Gynecologic Oncology. 2010 Academic Article GET IT
Times cited: 78
Role of secondary cytoreduction in recurrent ovarian cancer. Therapy. 2010 Report GET IT
Times cited: 1
Surveillance for the detection of recurrent ovarian cancer: Survival impact or lead-time bias?. Gynecologic Oncology. 2010 Academic Article GET IT
Times cited: 48
Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: An updated series. Gynecologic Oncology. 2010 Academic Article GET IT
Times cited: 32
Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller. International Journal of Gynecological Cancer. 2010 Academic Article GET IT
Times cited: 13
A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: Toward improving individualized cancer care. Gynecologic Oncology. 2010 Academic Article GET IT
Times cited: 63
Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. Gynecologic Oncology. 2010 Academic Article GET IT
Times cited: 21
Endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma with a background of complex atypical hyperplasia and final hysterectomy pathology. American Journal of Obstetrics and Gynecology. 2010 Academic Article GET IT
Times cited: 7
Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma. Gynecologic Oncology. 2010 Academic Article GET IT
Times cited: 28
The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum. Gynecologic Oncology. 2010 Academic Article GET IT
Times cited: 46
Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patients. Gynecologic Oncology. 2010 Academic Article GET IT
Times cited: 29
Cancer-related infertility in survivorship. International Journal of Gynecological Cancer. 2010 Review GET IT
Times cited: 54
Improving sentinel lymph node detection rates in endometrial cancer: How many cases are needed?. Gynecologic Oncology. 2009 Academic Article GET IT
Times cited: 83
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer. Gynecologic Oncology. 2009 Academic Article GET IT
Times cited: 18
Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers. Gynecologic Oncology. 2009 Academic Article GET IT
Times cited: 15
Reconstructive Techniques After Diaphragm Resection. Thoracic Surgery Clinics. 2009 Review GET IT
Times cited: 4
Response to "Indefinitely prolonged survival after relapse in advanced ovarian cancer: The other end of the telescope". Gynecologic Oncology. 2009 Article GET IT
The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecologic Oncology. 2009 Academic Article GET IT
Times cited: 117
Ureteroileocecal Appendicostomy Based Urinary Reservoir in Irradiated and Nonirradiated Patients. Journal of Urology. 2009 Academic Article GET IT
Times cited: 8
Vulvar mucinous adenocarcinoma associated with crohn's disease: Report of two cases. Gynecologic and Obstetric Investigation. 2009 Academic Article GET IT
Times cited: 6
A prospective randomized trial comparing patient-controlled epidural analgesia to patient-controlled intravenous analgesia on postoperative pain control and recovery after major open gynecologic cancer surgery. Obstetrical and Gynecological Survey. 2009 Comment GET IT
In response to: Establishing evidence for change in ovarian cancer surgery - Proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis. Gynecologic Oncology. 2009 Article GET IT
Times cited: 1
Long-term survival after fertility-sparing surgery for epithelial ovarian cancer. International Journal of Gynecological Cancer. 2009 Academic Article GET IT
Times cited: 53
A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer. Oncologist. 2009 Academic Article GET IT
Times cited: 40
Advanced cytoreductive surgery: American perspective. Gynecologic Oncology. 2009 Review GET IT
Times cited: 24
A prospective randomized trial comparing patient-controlled epidural analgesia to patient-controlled intravenous analgesia on postoperative pain control and recovery after major open gynecologic cancer surgery. Gynecologic Oncology. 2009 Academic Article GET IT
Times cited: 35
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecologic Oncology. 2009 Academic Article GET IT
Times cited: 358
Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies. Gynecologic Oncology. 2009 Academic Article GET IT
Times cited: 14
Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?. Gynecologic Oncology. 2009 Academic Article GET IT
Times cited: 150
Stage-specific outcomes of patients with Uterine leiomyosarcoma: A comparison of the international federation of gynecology and obstetrics and american joint committee on cancer staging systems. Journal of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 91
Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma. Gynecologic Oncology. 2009 Academic Article GET IT
Times cited: 75
Surgical Management of Recurrent Ovarian Cancer. Seminars in Oncology. 2009 Review GET IT
Times cited: 41
Ultrasonic surgical aspiration for vaginal intraepithelial neoplasia. International Journal of Gynecology and Obstetrics. 2009 Academic Article GET IT
Times cited: 12
Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer. Gynecologic Oncology. 2009 Academic Article GET IT
Times cited: 34
Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy. Gynecologic Oncology. 2009 Academic Article GET IT
Times cited: 91
A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma. Gynecologic Oncology. 2009 Academic Article GET IT
Times cited: 62
Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer. Gynecologic Oncology. 2009 Academic Article GET IT
Times cited: 31
Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis. Gynecologic Oncology. 2009 Review GET IT
Times cited: 258
Radical vaginal versus abdominal trachelectomy for stage IB1 cervical cancer: A comparison of surgical and pathologic outcomes. Gynecologic Oncology. 2009 Academic Article GET IT
Times cited: 81
Cytoreduction vs. neoadjuvant chemotherapy for ovarian cancer. Gynecologic Oncology. 2008 Academic Article GET IT
Times cited: 21
The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease. Gynecologic Oncology. 2008 Academic Article GET IT
Times cited: 111
Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma. Gynecologic Oncology. 2008 Academic Article GET IT
Times cited: 51
Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma. Gynecologic Oncology. 2008 Academic Article GET IT
Times cited: 136
Surgical and pathologic outcomes of fertility-sparing radical abdominal trachelectomy for FIGO stage IB1 cervical cancer. Gynecologic Oncology. 2008 Academic Article GET IT
Times cited: 82
The second edition of the Society of Gynecologic Oncologists Surgical Postgraduate Courses supplement. The 39th Annual Meeting of the Society of Gynecologic Oncologists, Tampa, Florida, USA, March 9-12, 2008. Gynecologic Oncology. 2008 Article GET IT
Treatment patterns of FIGO Stage IB2 cervical cancer: A single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy. Gynecologic Oncology. 2008 Academic Article GET IT
Times cited: 30
Upper abdominal surgical procedures: Liver mobilization and diaphragm peritonectomy/resection, splenectomy, and distal pancreatectomy. Gynecologic Oncology. 2008 Academic Article GET IT
Times cited: 36
Radical trachelectomy for cervical cancer: Postoperative physical andemotional adjustment concerns. Gynecologic Oncology. 2008 Academic Article GET IT
Times cited: 51
What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?. Gynecologic Oncology. 2008 Academic Article GET IT
Times cited: 26
Extended pelvic resections for recurrent uterine and cervical cancer: Out-of-the-box surgery. International Journal of Gynecological Cancer. 2008 Academic Article GET IT
Times cited: 24
Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease. International Journal of Gynecological Cancer. 2008 Academic Article GET IT
Times cited: 124
Surgical resection and reconstruction for advanced and recurrent gynecologic malignancies. Expert Review of Obstetrics and Gynecology. 2008 Report GET IT
Times cited: 1
Perihepatic metastases from ovarian cancer: Sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion. Radiology. 2008 Academic Article GET IT
Times cited: 36
Characterization of adnexal masses using feature analysis at contrast-enhanced helical computed tomography. Journal of Computer Assisted Tomography. 2008 Academic Article GET IT
Times cited: 17
Clear cell carcinoma of the cervix: A multi-institutional review in the post-DES era. Gynecologic Oncology. 2008 Academic Article GET IT
Times cited: 40
Colorectal stents for palliation of large-bowel obstructions in Recurrent gynecologic cancer: An updated series. Obstetrical and Gynecological Survey. 2008 Comment GET IT
In Brief. Current Problems in Surgery. 2008 Academic Article GET IT
Incidental Findings at Surgery-Part 2. Current Problems in Surgery. 2008 Review GET IT
Times cited: 2
Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?. American Journal of Obstetrics and Gynecology. 2008 Academic Article GET IT
Times cited: 67
Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer. Gynecologic Oncology. 2008 Academic Article GET IT
Times cited: 20
Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: An updated series. Gynecologic Oncology. 2008 Academic Article GET IT
Times cited: 65
The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. International Journal of Gynecological Cancer. 2008 Academic Article GET IT
Times cited: 126
Platinum resistance and impaired survival in patients with advanced primary peritoneal carcinoma: matched-case comparison with patients with epithelial ovarian carcinoma. American Journal of Obstetrics and Gynecology. 2008 Academic Article GET IT
Times cited: 16
The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer. Gynecologic Oncology. 2008 Academic Article GET IT
Times cited: 105
The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer. Gynecologic Oncology. 2008 Academic Article GET IT
Times cited: 85
Initial experience with Dargent's operation: The radical vaginal trachelectomy. Gynecologic Oncology. 2008 Academic Article GET IT
Times cited: 69
Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma. Gynecologic Oncology. 2008 Academic Article GET IT
Times cited: 46
Operative management of primary epithelial ovarian cancer. Current Oncology Reports. 2007 Article GET IT
Times cited: 7
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less. Journal of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 45
A new frontier for quality of care in gynecologic oncology surgery: Multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model. Gynecologic Oncology. 2007 Academic Article GET IT
Times cited: 102
Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer. Gynecologic Oncology. 2007 Academic Article GET IT
Times cited: 18
A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors. Investigational New Drugs. 2007 Academic Article GET IT
Times cited: 16
Comparing surgical outcomes in obese women undergoing laparotomy, laparoscopy, or laparotomy with panniculectomy for the staging of uterine malignancy. Annals of Surgical Oncology. 2007 Academic Article GET IT
Times cited: 58
Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy. Gynecologic Oncology. 2007 Academic Article GET IT
Times cited: 53
A prospective study of the accuracy of ¹⁸Fluorodeoxyglucose positron emission tomography (¹⁸FDG PET) in identifying sites of metastasis prior to pelvic exenteration. Gynecologic Oncology. 2007 Academic Article GET IT
Times cited: 60
Platinum-based neoadjuvant chemotherapy for advanced ovarian cancer: A meta-analysis. Gynecologic Oncology. 2007 Information Resource GET IT
Times cited: 1
Report of the Clinical Protocol Committee: Development of Randomized Trials for Malignant Bowel Obstruction. Journal of Pain and Symptom Management. 2007 Conference Paper GET IT
Times cited: 72
Carcinosarcoma of the ovary treated with platinum and taxane: The memorial Sloan-Kettering Cancer Center experience. Gynecologic Oncology. 2007 Academic Article GET IT
Times cited: 48
Twelve-year experience in the management of endometrial cancer: A change in surgical and postoperative radiation approaches. Gynecologic Oncology. 2007 Academic Article GET IT
Times cited: 82
A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer. International Journal of Gynecological Cancer. 2007 Academic Article GET IT
Times cited: 10
Clinicopathologic features of rhabdomyosarcoma of gynecologic origin in adults. American Journal of Surgical Pathology. 2007 Academic Article GET IT
Times cited: 59
Primary retroperitoneal lymphangioleiomyomatosis in a postmenopausal woman: A case report and review of the literature. International Journal of Gynecological Cancer. 2007 Review GET IT
Times cited: 16
The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions. Gynecologic Oncology. 2007 Academic Article GET IT
Times cited: 46
The outcomes of patients with positive margins after excision for intraepithelial Paget's disease of the vulva. Gynecologic Oncology. 2007 Academic Article GET IT
Times cited: 84
Delaying the primary surgical effort for advanced ovarian cancer: A systematic review of neoadjuvant chemotherapy and interval cytoreduction. Gynecologic Oncology. 2007 Review GET IT
Times cited: 146
Distal partial gastrectomy and gastrojejunal anastomosis for recurrent ovarian cancer. Gynecologic Oncology. 2007 Academic Article GET IT
Times cited: 4
Extended pelvic resection of iliacus muscle and femoral nerve for isolated recurrent uterine cancer. Gynecologic Oncology. 2007 Academic Article GET IT
Times cited: 1
Hand-assisted laparoscopic splenectomy for isolated ovarian cancer recurrence. Gynecologic Oncology. 2007 Academic Article GET IT
Times cited: 3
Liver mobilization and diaphragm peritonectomy/resection. Gynecologic Oncology. 2007 Academic Article GET IT
Times cited: 19
Retroperitoneal lymph node dissection. Gynecologic Oncology. 2007 Review GET IT
Times cited: 3
Superior pubic rami resection for isolated recurrent uterine cancer. Gynecologic Oncology. 2007 Academic Article GET IT
Times cited: 2
CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy. Gynecologic Oncology. 2007 Academic Article GET IT
Times cited: 53
Resection of recurrent cervical cancer after total pelvic exenteration. International Journal of Gynecological Cancer. 2007 Academic Article GET IT
Times cited: 10
Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: Technique and review of the literature. Gynecologic Oncology. 2006 Review GET IT
Times cited: 113
Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 51
Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysis. Gynecologic Oncology. 2006 Review GET IT
Times cited: 262
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 244
Cystoscopic temporary ureteral catheterization during radical vaginal and abdominal trachelectomy. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 22
Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: A retrospective study. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 49
The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: A 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 222
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 416
Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 66
En bloc resection of diaphragm with lung for recurrent ovarian cancer: A case report. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 8
Surgical resection of recurrent endometrial carcinoma. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 50
Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: Pathologic complete response and longitudinal assessment of impact on cognitive functioning. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 26
Prognostic importance of "normal" CA125 levels prior to consolidation chemotherapy in advanced ovarian cancer. American Journal of Oncology Review. 2006 Comment
The significance of cytological mesothelial atypia diagnosed from peritoneal washings performed during risk-reducing salpingo-oophorectomy. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 7
Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 8
Aggressive surgery and ovarian cancer [5]. Journal of Clinical Oncology. 2006 Article GET IT
Times cited: 8
Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer. 2006 Academic Article GET IT
Times cited: 246
Laparoscopic and hand-assisted laparoscopic splenectomy for recurrent and persistent ovarian cancer. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 22
Laparoscopic findings during adnexal surgery in women with a history of nongynecologic malignancy. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 9
Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer. International Journal of Gynecological Cancer. 2006 Academic Article GET IT
Times cited: 26
Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 42
Full-thickness diaphragmatic resection for stage IV ovarian carcinoma using the EndoGIA stapling device followed by diaphragmatic reconstruction using a Gore-tex® graft: A case report and review of the literature. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 13
Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies. Gynecologic Oncology. 2006 Academic Article GET IT
Times cited: 11
Neoadjuvant chemotherapy for ovarian cancer: Pro versus con. Women's Oncology Review. 2006 Report GET IT
Times cited: 1
p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas. International Journal of Gynecological Cancer. 2006 Academic Article GET IT
Times cited: 27
Conservative management of pneumatosis intestinalis. Gynecologic Oncology. 2005 Academic Article GET IT
Times cited: 14
Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecologic Oncology. 2005 Academic Article GET IT
Times cited: 109
Role of imaging in pretreatment evaluation of early invasive cervical cancer: Results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. Journal of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 151
Successful pregnancies following fertility-preserving treatment for ovarian carcinoma. Nature Clinical Practice Oncology. 2005 Academic Article GET IT
Times cited: 3
Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: Results of intergroup protocol ACRIN 6651/GOG 183. Journal of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 56
Transfusion utilization during adnexal or peritoneal cancer surgery: Effects on symptomatic venous thromboembolism and survival. Gynecologic Oncology. 2005 Academic Article GET IT
Times cited: 45
Fertility-sparing options for patients with gynecologic malignancies. Oncologist. 2005 Review GET IT
Times cited: 29
Celiac disease presenting as a paraneoplastic syndrome in a patient with synchronous endometrial and ovarian cancers. Gynecologic Oncology. 2005 Academic Article GET IT
Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. International Journal of Radiation Oncology Biology Physics. 2005 Academic Article GET IT
Times cited: 102
The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers. American Journal of Obstetrics and Gynecology. 2005 Academic Article GET IT
Times cited: 130
Borderline endometrioid tumor arising in a paratubal cyst: A case report. Gynecologic Oncology. 2005 Academic Article GET IT
Times cited: 14
Cervical cancer: Current management of early/late disease. Surgical Oncology Clinics of North America. 2005 Review GET IT
Gynecologic cancer treatment and the impact of cancer-related infertility. Gynecologic Oncology. 2005 Academic Article GET IT
Times cited: 126
The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma. Cancer. 2005 Academic Article GET IT
Times cited: 35
Prolonged survival following salvage surgery for chemorefractory ovarian immature teratoma: A case report and review of the literature. Gynecologic Oncology. 2005 Review GET IT
Times cited: 14
Pilot study prospectively evaluating the use of the measurement of preoperative sonographic endometrial thickness in postmenopausal patients with endometrial cancer. Menopause. 2005 Academic Article GET IT
Times cited: 11
Update on surgical treatment for endometrial cancer. Expert Review of Anticancer Therapy. 2005 Review GET IT
Times cited: 3
A fertility-sparing alternative to radical hysterectomy: How many patients may be eligible?. Gynecologic Oncology. 2004 Academic Article GET IT
Times cited: 122
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube and primary peritoneal cancer: A change in surgical approach. Women's Oncology Review. 2004 Academic Article GET IT
The use of colorectal stents for palliation of large-bowel obstruction due to recurrent gynecologic cancer. Gynecologic Oncology. 2004 Academic Article GET IT
Times cited: 35
Anal dysplasia in HIV-infected women with cervical and vulvar dysplasia. Journal of Lower Genital Tract Disease. 2004 Academic Article GET IT
Times cited: 9
Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma. Gynecologic Oncology. 2004 Academic Article GET IT
Times cited: 39
Ten-year experience with laparoscopy on a gynecologic oncology service: Analysis of risk factors for complications and conversion to laparotomy. American Journal of Obstetrics and Gynecology. 2004 Academic Article GET IT
Times cited: 58
Tertiary cytoreduction in patients with recurrent ovarian carcinoma. Gynecologic Oncology. 2004 Academic Article GET IT
Times cited: 61
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: A change in surgical approach. Gynecologic Oncology. 2004 Academic Article GET IT
Times cited: 247
The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions. Gynecologic Oncology. 2004 Academic Article GET IT
Times cited: 34
Use of an ureteroileocecal appendicostomy urinary reservoir in patients with recurrent pelvic malignancies treated with radiation. Gynecologic Oncology. 2004 Academic Article GET IT
Times cited: 14
Intraperitoneal Cisplatin with Intraperitoneal Gemcitabine in Patients with Epithelial Ovarian Cancer: Results of a Phase I/II Trial. Clinical Cancer Research. 2004 Academic Article GET IT
Times cited: 32
Surgical gytoreductíon in ovarian cancer. ONCOLOGY. 2004 Review GET IT
Times cited: 11
Detection of Residual Subclinical Ovarian Carcinoma after Completion of Adjuvant Chemotherapy. Clinical Cancer Research. 2004 Academic Article GET IT
Times cited: 7
Costs of treatment and outcomes associated with second-line therapy and greater for relapsed ovarian cancer. Gynecologic Oncology. 2004 Academic Article GET IT
Times cited: 6
Subcutaneous tumor implantation after laparoscopic procedures in women with malignant disease. Obstetrics and Gynecology. 2004 Academic Article GET IT
Times cited: 65
Brief report: Total pelvic exenteration - A retrospective clinical needs assessment. Psycho-Oncology. 2004 Academic Article GET IT
Times cited: 16
Role of CT in the Management of Recurrent Ovarian Cancer. American Journal of Roentgenology. 2004 Academic Article GET IT
Times cited: 38
Resection of recurrent ovarian or fallopian tube carcinoma involving the liver. Gynecologic Oncology. 2003 Article GET IT
Times cited: 43
Total laparoscopic radical hysterectomy with pelvic lymphadenectomy using the argon-beam coagulator: Pilot data and comparison to laparotomy. Gynecologic Oncology. 2003 Academic Article GET IT
Times cited: 160
Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus. Gynecologic Oncology. 2003 Academic Article GET IT
Times cited: 119
The effects of CO2 pneumoperitoneum on the survival of women with persistent metastatic ovarian cancer. Gynecologic Oncology. 2003 Academic Article GET IT
Times cited: 32
9Transperitoneal laparoscopic pelvic and para-aortic lymph node dissection using the argon-beam coagulator and monopolar instruments: An 8-year study and description of technique. Gynecologic Oncology. 2003 Academic Article GET IT
Times cited: 54
The use of MRI in the diagnosis and management of a bulky cervical carcinoma. Gynecologic Oncology. 2003 Academic Article GET IT
Times cited: 6
Palliative surgery for bowel obstruction in recurrent ovarian cancer: An updated series. Gynecologic Oncology. 2003 Academic Article GET IT
Times cited: 73
Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy. Gynecologic Oncology. 2003 Academic Article GET IT
Times cited: 103
Clinically inapparent invasive vulvar carcinoma in an area of persistent Paget's disease: A case report. Gynecologic Oncology. 2003 Academic Article GET IT
Times cited: 5
Craniotomy for central nervous system metastases in epithelial ovarian carcinoma. Gynecologic Oncology. 2002 Academic Article GET IT
Times cited: 25
Major hepatectomy at interval debulking for Stage IV ovarian carcinoma: A case report. Gynecologic Oncology. 2002 Academic Article GET IT
Times cited: 12
Peritoneal metastases: Detection with spiral CT in patients with ovarian cancer. Radiology. 2002 Academic Article GET IT
Times cited: 230
Recurrent cervical cancer. Current treatment options in oncology. 2002 Review GET IT
Times cited: 40
Surgical management of advanced or recurrent endometrial cancer. Surgical Clinics of North America. 2001 Article GET IT
Times cited: 22
The benefit of a special elective gynecologic oncology program for obstetrics and gynecology residents. European Journal of Gynaecological Oncology. 2001 Academic Article GET IT
Times cited: 1
Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecologic Oncology. 2001 Academic Article GET IT
Times cited: 190
The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patients. Gynecologic Oncology. 2001 Academic Article GET IT
Times cited: 20
Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers. International Journal of Radiation Oncology Biology Physics. 2001 Academic Article GET IT
Times cited: 63
Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer. Gynecologic Oncology. 2001 Academic Article GET IT
Times cited: 18
The role of laparoscopy in second-look evaluations for ovarian cancer. Gynecologic Oncology. 2001 Academic Article GET IT
Times cited: 54
Sampling paraaortic lymph nodes in gynecologic cancers. CME Journal of Gynecologic Oncology. 2000 Report
Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies. Gynecologic Oncology. 2000 Academic Article GET IT
Times cited: 43
Advanced ovarian cancer. Current treatment options in oncology. 2000 Review GET IT
Times cited: 24
Clinicopatholic features of BRCA-linked and sporadic ovarian cancer. JAMA - Journal of the American Medical Association. 2000 Academic Article GET IT
Times cited: 447
The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. Gynecologic Oncology. 2000 Academic Article GET IT
Times cited: 163
Primary intravenous paclitaxel and platinum chemotherapy for high-risk Stage I epithelial ovarian carcinoma. European Journal of Gynaecological Oncology. 1999 Academic Article GET IT
Times cited: 2
Long-term experience in the surgical management of cancer of the uterine cervix. Seminars in Surgical Oncology. 1999 Article GET IT
Times cited: 23
Laparoscopy in gynecologic malignancies. ONCOLOGY. 1999 Review GET IT
Times cited: 17
The accuracy of frozen-section diagnosis in metastatic breast and colorectal carcinoma to the adnexa. Gynecologic Oncology. 1999 Academic Article GET IT
Times cited: 9
Gynecologic cancer and laparoscopy. Obstetrics and Gynecology Clinics of North America. 1999 Article GET IT
Times cited: 16
Splenectomy in recurrent epithelial ovarian cancer. Gynecologic Oncology. 1999 Review GET IT
Times cited: 67
State of the art surgical management of ovarian cancer. Cancer Research Therapy and Control. 1999 Report
Times cited: 2
Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings. Obstetrics and Gynecology. 1999 Academic Article GET IT
Times cited: 145
The diagnosis and management of vulvar cancer. Primary Care Update for Ob/Gyns. 1999 Report GET IT
Times cited: 3
Novel agents for intraperitoneal chemotherapy in patients with epithelial ovarian cancer. CME Journal of Gynecologic Oncology. 1998 Academic Article
The role of surgery in the management of ovarian cancer: Primary and interval cytoreductive surgery. Seminars in Oncology. 1998 Review GET IT
Times cited: 75
The role of surgical cytoreduction in Stage IV endometrial carcinoma. Gynecologic Oncology. 1997 Academic Article GET IT
Times cited: 101
Hepatic resection for metastatic gynecologic carcinomas. Gynecologic Oncology. 1997 Review GET IT
Times cited: 52
The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma. Gynecologic Oncology. 1997 Review GET IT
Times cited: 83
Laparoscopic management of adnexal masses in women with a history of nongynecologic malignancy. Obstetrics and Gynecology. 1995 Academic Article GET IT
Times cited: 21
Serum ionized magnesium levels during intravenous MGSO4 therapy of preeclamptic women. Acta obstetricia et gynecologica Scandinavica. 1995 Academic Article GET IT
Times cited: 9
Nonfatal venous air embolism during cesarean section: A case report and review of the literature. Obstetrical and Gynecological Survey. 1994 Review GET IT
Times cited: 36

VIVO Weill Cornell Medical College

Dennis Chi Professor of Obstetrics and Gynecology

Publications

Selected publications

Background

Education and Training